Advertisement

Topics

Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

16:15 EDT 14 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage biopharmaceutical company focused on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced financial r...

Other Sources for this Article

Argot Partners
Investors:
Natalie Wildenradt, 646-681-8192
natalie@argotpartners.com
or
Media:
David Rosen, 212-600-1902
david.rosen@argotpartners.com

NEXT ARTICLE

More From BioPortfolio on "Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update"

Advertisement
Quick Search
Advertisement
Advertisement